Pledge Therapeutics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pledge Therapeutics
Largest movements
- Cash -€47,290
down €47,290 (-57.3%), from €82,500 to €35,210
mainly Net result for the year (-€688,788) and Receivables within one year (-€15,591)
- Tangible fixed assets -€34,091
down €34,091 (-14.3%), from €237,635 to €203,544
of which Plant, machinery and equipment: -€33,946
- Receivables within one year +€15,591
up €15,591 (+44.7%), from €34,907 to €50,498
- Profit (loss) carried forward -€688,788
down €688,788 (-40.3%), from -€1.7m to -€2.4m
- Other debts +€585,701
up €585,701 (+29.7%), from €2.0m to €2.6m
- Tax, wage and social debts +€33,897
up €33,897 (+50.1%), from €67,670 to €101,568
- Accrued charges and deferred income +€5,014
up €5,014 (+122%), from €4,124 to €9,138
- Trade debts -€4,721
down €4,721 (-16.9%), from €27,985 to €23,265
- Staff costs +€174,498
up €174,498 (+46.8%), from €372,627 to €547,125
- Gross operating margin +€46,681
up €46,681 (+32.4%), from -€144,155 to -€97,474
- Depreciation +€3,281
up €3,281 (+7.9%), from €41,326 to €44,607
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €361,319 | €292,422 | -€68,897 | -19.1% |
| Fixed assets | 21/28 | €240,806 | €206,715 | -€34,091 | -14.2% |
| Tangible fixed assets | 22/27 | €237,635 | €203,544 | -€34,091 | -14.3% |
| Plant, machinery and equipment | 23 | €236,620 | €202,674 | -€33,946 | -14.3% |
| Other tangible fixed assets | 26 | €1,015 | €870 | -€145 | -14.3% |
| Financial fixed assets | 28 | €3,171 | €3,171 | = | 0.0% |
| Current assets | 29/58 | €120,513 | €85,707 | -€34,805 | -28.9% |
| Amounts receivable within one year | 40/41 | €34,907 | €50,498 | +€15,591 | +44.7% |
| Other amounts receivable | 41 | €34,907 | €50,498 | +€15,591 | +44.7% |
| Cash at bank and in hand | 54/58 | €82,500 | €35,210 | -€47,290 | -57.3% |
| Deferred charges and accrued income | 490/1 | €3,106 | - | -€3,106 | |
| Total equity and liabilities | 10/49 | €361,319 | €292,422 | -€68,897 | -19.1% |
| Equity | 10/15 | -€1,707,462 | -€2,396,250 | -€688,788 | -40.3% |
| Contributions | 10/11 | €500 | €500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,707,962 | -€2,396,750 | -€688,788 | -40.3% |
| Amounts payable | 17/49 | €2,068,781 | €2,688,672 | +€619,892 | +30.0% |
| Amounts payable within one year | 42/48 | €2,064,657 | €2,679,535 | +€614,878 | +29.8% |
| Trade debts | 44 | €27,985 | €23,265 | -€4,721 | -16.9% |
| Suppliers | 440/4 | €27,985 | €23,265 | -€4,721 | -16.9% |
| Taxes, remuneration and social security | 45 | €67,670 | €101,568 | +€33,897 | +50.1% |
| Remuneration and social security | 454/9 | €67,670 | €101,568 | +€33,897 | +50.1% |
| Other amounts payable | 47/48 | €1,969,001 | €2,554,702 | +€585,701 | +29.7% |
| Accrued charges and deferred income | 492/3 | €4,124 | €9,138 | +€5,014 | +122% |
| Remuneration, social security and pensions | 62 | €372,627 | €547,125 | +€174,498 | +46.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,326 | €44,607 | +€3,281 | +7.9% |
| Other operating charges | 640/8 | €955 | - | -€955 | |
| Gross operating margin | 9900 | -€144,155 | -€97,474 | +€46,681 | +32.4% |
| Operating profit (loss) | 9901 | -€559,063 | -€689,206 | -€130,143 | -23.3% |
| Financial income | 75/76B | €936 | €1,395 | +€459 | +49.0% |
| Recurring financial income | 75 | €936 | €1,395 | +€459 | +49.0% |
| Financial charges | 65/66B | €527 | €978 | +€450 | +85.4% |
| Recurring financial charges | 65 | €527 | €978 | +€450 | +85.4% |
| Profit (loss) for the period before taxes | 9903 | -€558,654 | -€688,788 | -€130,134 | -23.3% |
| Profit (loss) for the period | 9904 | -€558,654 | -€688,788 | -€130,134 | -23.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€558,654 | -€688,788 | -€130,134 | -23.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.